MS News: July 2016

Clinical Trials


  1. Childhood MS: A guide for parents
  2. Queen’s University Belfast Awarded £2M in Bid to Reverse Myelin Damage in MS
  3. Exploring Multiple Sclerosis from the Inside


  1. Rare Form of MS Could Be Caused by Single Genetic Mutation
  2. Gut Bacteria Differs in Multiple Sclerosis Patients
  3. Antibody Created in Lab Treats MS in Mice by Preventing Immune Cells from Piercing Blood-Brain Barrier
  4. Nearly 75% of MS Patients in UK Study Went Through Progressive Decline Prior to Death
  5. Retinal Thickness May Mark Cognitive Decline
  6. Does spinal trauma trigger Multiple Sclerosis?
  7. Multiple sclerosis: IVIG reduces postpartum relapse rate
  8. Autoimmune diseases may be side effect of a strong immune system
  9. Development of a sensitive outcome for economical drug screening for progressive multiple ..
  10. Anticoagulants, Multiple Sclerosis Fatigue Studies Receive $5.5M in PCORI Funding
  11. Guidelines for Neuropsychological Research in Multiple Sclerosis
  12. Obesity and multiple sclerosis: Is there a causal relationship?
  13. Scientists want to use parasitic worms to treat multiple sclerosis
  14. Tracking brain atrophy in MS could become routine, thanks to software developed at UB
  15. Predictors of Long-Term Disability in Multiple Sclerosis
  16. Multiple Sclerosis and Trigeminal Neuralgia: A Two-Hit Hypothesis

Clinical Trials

  1. 127 Progressive MS Patients Finish Treatment in Phase 2 Study of Ibudilast, MediciNova Reports
  2. Study of Potential Therapy for Relapsing MS That Targets B-Cells Now Recruiting Patients in US
  3. Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment
  4. A Phase I Study: Safety of RG2077 (CTLA4-IgG4m)
  5. Fingolimod (Gilenya) Seen to Promote Peripheral Nerve Regeneration in Mice, Aiding Remyelination

Treatment News

  1. Disease Modifying Drugs Seen to Help Protect MS Patients with Benign Status from Greater Disability
  2. Low-Quality Generic MS Drugs Can Be Both Toxic and Ineffective, Study Reports
  3. Advanced Structural and Functional Brain MRI in Multiple Sclerosis
  4. Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis
  5. Ampyra (dalfampridine) Cost, Dosage, and Prescribing Information for Multiple Sclerosis
  6. Multiple Sclerosis Prognosis and Your Life Expectancy
  7. Medical marijuana: Does research back up claims of therapeutic benefits?
  8. FDA Approves Syndros, Marijuana In Liquid Form — But Is It More Effective Than Pills?
  9. ‘Ireland is behind the times’: Should cannabis be legalised for medical use?
  10. Is Lemtrada (Alemtuzumab) Chemotherapy?
  11. Pre-Trigeminal Neuralgia Symptoms: When You Should See a Doctor
  12. [VIDEO] Symptoms of vitamin D deficiency
  13. Cancer Risk with Mitoxantrone

Stem Cell Treatment

  1. Hundreds of U.S. Clinics Sell Unproved Stem Cell Treatments
  2. Stem Cell Therapies Are Still Mostly Theory, Yet Clinics Are Flourishing
  3. 5 Things You Probably Don’t Know About Stem Cell Treatments
  4. 9 Hematopoietic Stem Cell Transplantation (HSCT) Articles You Must Read
  5. Study That May Benefit MS Patients Awarded Grant from National Stem Cell Foundation

General News, with many thanks to Barts MS Blog

  1. Mapping the Brain
  2. ClinicSpeak & BrainHealth: finally a version for MSer
  3. Studies will give patients evidence to help them choose among therapies

Mental Health

  1. The Relationship Between MS and Suicide
  2. Studying How People with Multiple Sclerosis Experience Prognostic Uncertainty
  3. Depression in Multiple Sclerosis Linked to Brain Inflammation
  4. 10 Ways to Stop Stress Now
  5. Mindfulness Meditation: Easing MS Anxiety


  1. Could Drinking Four Cups of Coffee a Day Help You Fight MS?
  2. How to eat right for brain health
  3. Salt intake in multiple sclerosis: friend or foe?
  4. Diet analysis paper


  1. Multiple sclerosis patients may improve cognition with regular walking, cycling, and yoga
  2. Multiple sclerosis: aquatic exercise improves balance, gait
  3. Systematic, Evidence-Based Review of Exercise, Physical Activity, and Physical Fitness Effects on Cognition in Persons with Multiple Sclerosis
  4. The Adaptive Yoga Book For People Living With Multiple Sclerosis
  5. Video Games May Improve Brain Function Of Multiple Sclerosis Patients


  1. 10 Multiple Sclerosis’ Self-Managing Tips
  2. Five Tips to Care for a Loved One Diagnosed with Multiple Sclerosis
  3. Strategies for Keeping Cool with MS in the Summer Heat 
  4. Telemedicine Can Make Life Easier for Multiple Sclerosis Patients
  5. Talking About Accessible Travel
  6. The Limits of Google: How Patients Can Find Out What Works In Medical Care
  7. ‘My MS Manager’ Named One of Best Apps for MS for 4th Year
  8. Pathmaker Neurosystems named as finalist for the Innovation Prize 2016
  9. Increasing Disability in MS Matched by Rising Financial, Personal and Work-related Burdens
  10. A lesser-known multiple-sclerosis issue — money problems
  11. New seniors study suggests Vitamin D could prevent cognitive decline
  12. High Doses of Vitamin D Unlikely to Help MS Patients, But Daily Low Dose Good for All, UK Group …
  13. Multiple Sclerosis Prognosis and Your Life Expectancy

When New Symptoms Visit You

  1. [VIDEO] Cognitive Fatigue in MS
  2. Swallowing hard: dysphagia and MS
  3. Optic Neuritis Commonly Asked Questions
  4. What is the Difference Between Relapsing and Progressive MS?

Business News

  1. Increased Prevalence of Neurological Disorders to Create Opportunities for the Neurodiagnostic
  2. Pharma Industry Outlook: Fundamentals Remain Strong
  3. An Investing Overview of the Multiple Sclerosis MarketInvestor’s Watch List: Ionis Pharmaceuticals, Inc. (IONS), Visteon Corporation (VC), Textron Inc.
  4. Multiple sclerosis drug pipeline
  5. Bayer beats expectations in 2nd-qtr results; raises guidance
  6. Merck KGaA’s Investigational MS Therapy Cladribine Gets EMA Marketing Authorization Application Review
  7. Merck KGaA’s Multiple Sclerosis Drug under Review in EU
  8. Avonex (Multiple Sclerosis) Market Research Report Now Available at Research Corridor
  9. What Are Analysts Saying About Q2 at Biotech’s Big 4? Amgen, Biogen, Celgene, Gilead
  10. Aubagio Multiple Sclerosis Market Research Report Now Available at Research Corridor
  11. Sanofi determined to get Medivation as sales slide
  12. AbbVie Results Boosted by Humira, Pipeline Growth


  1. 7 Videos About Incontinence and Bladder Control You Must Watch


©Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me, 2011-2016. Unauthorized use and/or duplication of this material without express and written permission from this blog’s author and/or owner are strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me with appropriate and specific direction to the original content.

Your thoughts?

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.